Novo's New Weight-Loss Pill Keeps the Pounds Coming Off

People who switched from weight-loss injections to Novo's Wegovy pill lost even more weight, a new real-world study shows.

Weight-loss injections have taken the world by storm — but now a pill might do the job just as well, or even better.

Novo Nordisk (a large Danish drug company, whose stock trades under the ticker "NVO") presented new data this week showing that people who switched from weight-loss shots to its new Wegovy pill kept losing weight instead of just maintaining it.

The study looked at 194 patients who were overweight or living with obesity. Half started on Novo's Wegovy injection and half on rival Eli Lilly's (ticker "LLY") Zepbound shot. All later switched to the Wegovy pill.

Here are the key numbers after three months on the pill:

Patients lost about 4% of their weight — roughly 8.8 extra pounds on average.
2 in 5 achieved 5% or more weight loss.
82% reported at least one health improvement.
75% said they were happy they switched to a pill.

Why does this matter? A pill is far more convenient than a weekly shot. As Novo's chief scientific officer noted, some patients travel a lot and don't want to worry about keeping injections refrigerated. This suggests people may not need shots forever — they could switch to easier options.

One big caveat: this was a "real-world study" (research based on everyday patient data rather than a strict, controlled lab trial). It can show patterns but can't prove cause and effect. The data was also self-reported, meaning results could be biased.

Novo also shared early results on CagriSema, an experimental next-generation drug expected to launch early next year. It reportedly reduced "food noise" (constant thoughts about food) and improved organ and bone health.

The bottom line: Novo is betting that convenient pills could be the future of weight-loss treatment. If patients prefer pills and still get strong results, it could reshape a booming market — and intensify competition with Eli Lilly.

This is an AI-generated summary. Read the original article at: https://www.cnbc.com/2026/09/30/novo-wegovy-pill-weight-loss-injections.html